Signet Healthcare Partners backs Juno Pharmaceuticals
Signet Healthcare Partners has made a growth investment in Juno Pharmaceuticals Corp, a Toronto-based specialty generics pharmaceuticals company.
24 February 2022•2 mins read
Signet Healthcare Partners has made a growth investment in Juno Pharmaceuticals Corp, a Toronto-based specialty generics pharmaceuticals company.
Mason Wells explores sale of KJ Holding, parent of lemonade brand Calypso, sources say
6 hours ago · 2 mins read
Stellex completes sale of UK gear maker David Brown Defence to Renk
6 hours ago · 2 mins read
Linden Capital Partners strikes deal to back AnewHealth alongside Nautic
7 hours ago · 2 mins read
Archimed completes carve-out of Standard BioTools’ microfluidics unit, now Biomark Scientific
7 hours ago · 1 min read
Blue Point’s RSI expands into Indiana with Wells Masonry add-on
7 hours ago · 2 mins read
McNally Capital’s Tenica acquires intelligence contractor Trinity Enterprise Services
7 hours ago · 1 min read
L Squared acquires vegetation manager Edko in first Fund V platform deal
8 hours ago · 2 mins read
